Axogen (MEX:AXGN) Other Long-Term Liabilities: MXN0.14 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AXGN Axogen Inc MEX:AXGN
44 GF Score
Price MXN800.66
GF Value MXN1,610.37
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Axogen Other Long-Term Liabilities?

Axogen MEX:AXGN 44 Other Long-Term Liabilities is MXN0.14 Mil as of Jun. 2026. GuruFocus rates MEX:AXGN with a GF Score™ of 44/100 and a GF Value™ of MXN1,610.37 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Axogen's other long-term liabilities for the quarter that ended in Jun. 2026 was MXN0.14 Mil.

Axogen's quarterly other long-term liabilities declined from Dec. 2025 (MXN4.03 Mil) to Mar. 2026 (MXN0.14 Mil) but then increased from Mar. 2026 (MXN0.14 Mil) to Jun. 2026 (MXN0.14 Mil).

Axogen's annual other long-term liabilities declined from Dec. 2023 (MXN2.99 Mil) to Dec. 2024 (MXN2.49 Mil) but then increased from Dec. 2024 (MXN2.49 Mil) to Dec. 2025 (MXN4.03 Mil).

Axogen Other Long-Term Liabilities Related Terms

Axogen Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Axogen's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Axogen Other Long-Term Liabilities Chart

Axogen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.56 4.52 2.99 2.49 4.03

Axogen Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 2.01 4.03 0.14 0.14
MEX:AXGN
44GF Score
Axogen Inc MEX:AXGN
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Axogen Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of MXN0.14 Mil mean?
Axogen (MEX:AXGN) has a Other Long-Term Liabilities of MXN0.14 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Axogen and its competitors.
Is Axogen's Other Long-Term Liabilities too high?
Axogen's current Other Long-Term Liabilities is MXN0.14 Mil. Overall, Axogen has a GF Score™ of 44/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's Other Long-Term Liabilities compare to ?
Axogen's Other Long-Term Liabilities of MXN0.14 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Devices & Instruments company?
A good Other Long-Term Liabilities depends on the Medical Devices & Instruments industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Axogen and its competitors. Axogen's current Other Long-Term Liabilities is MXN0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (MEX:AXGN) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,610.37, compared to a current price of MXN800.66 — trading 50.3% below its estimated fair value. The current Other Long-Term Liabilities is MXN0.14 Mil. Axogen's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Axogen (MEX:AXGN), the current Other Long-Term Liabilities is MXN0.14 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (MEX:AXGN) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be undervalued. The current stock price of MXN800.66 is trading 50.3% below its estimated GF Value™ of MXN1,610.37. GuruFocus considers Axogen to be Significantly Undervalued.

Key valuation signals for MEX:AXGN:

  • Other Long-Term Liabilities: MXN0.14 Mil
  • GF Value™: MXN1,610.37 vs. price of MXN800.66 (50.3% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the MEX:AXGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Comparable Companies
Other Exchanges AXGN:USA0HKD:UKLT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
44GF Score

Get the complete analysis for MEX:AXGN

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN800.66
Price
MXN1,610.37
GF Value